학술논문
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
Document Type
Article
Author
Source
In European Journal of Cancer May 2023 184:1-9
Subject
Language
ISSN
0959-8049